• Home
  • Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer.

Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer.

Author List
Garrido-Castro AC, Regan MM, Niman SM, Nakhlis F, Remolano C, Rosenbluth JM, Block C, Warren LE, Bellon JR, Yeh E, Harrison BT, Troll E, Lin NU, Tolaney SM, Overmoyer B, Lynce F
Publication
NPJ breast cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/410623191
Publication Year
2023
PubMed ID
37268625
Publication Title
Garrido-Castro AC, Regan MM, Niman SM, Nakhlis F, Remolano C, Rosenbluth JM, Block C, Warren LE, Bellon JR, Yeh E, Harrison BT, Troll E, Lin NU, Tolaney SM, Overmoyer B, Lynce F. Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer. NPJ Breast Cancer. 2023 Jun 02; 9(1):50.